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Abstract
Evidence from the Global Burden of Disease studies suggests that osteoarthritis (OA) is a significant cause of disability glob-
ally; however, it is less clear how much of this burden exists in low-income and lower middle-income countries. This study 
aims to determine the prevalence of OA in people living in low-income and lower middle-income countries. Four electronic 
databases (MEDLINE, EMBASE, CINAHL and Web of Science) were systematically searched from inception to October 
2018 for population-based studies. We included studies reporting the prevalence of OA among people aged 15 years and over 
in low-income and lower middle-income countries. The prevalence estimates were pooled across studies using random effects 
meta-analysis. Our study was registered with PROSPERO, number CRD42018112870.The search identified 7414 articles, 
of which 356 articles were selected for full text assessment. 34 studies were eligible and included in the systematic review 
and meta-analysis. The pooled prevalence of OA was 16·05% (95% confidence interval (CI) 12·55–19·89), with studies dem-
onstrating a substantial degree of heterogeneity (I2 = 99·50%). The pooled prevalence of OA was 16.4% (CI 11·60–21.78%) 
in South Asia, 15.7% (CI 5·31–30·25%) in East Asia and Pacific, and 14.2% (CI 7·95–21·89%) in Sub Saharan Africa. The 
meta-regression analysis showed that publication year, study sample size, risk of bias score and country-income categories 
were significantly associated with the variations in the prevalence estimates. The prevalence of OA is high in low-income 
and lower middle-income countries, with almost one in six of the study participants reported to have OA. With the changing 
population demographics and the shift to the emergence of non-communicable diseases, targeted public health strategies 
are urgently needed to address this growing epidemic in the aging population.
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COPCORD  Community oriented program for control of 
rheumatic diseases
SSA  Sub-Saharan Africa
EAP  East Asia and Pacific
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Introduction
Low- and middle-income countries (LMICs) are experienc-
ing a dramatic shift in the burden of disease from commu-
nicable to non-communicable disease (NCD) [1]. This is 
causing a significant challenge for governments and health 
care systems that are already strained due to the epidemics 
associated with HIV/AIDS, other infectious diseases and 
weak health systems. The prevalence of NCD continues to 
grow and was responsible for 70% of deaths worldwide in 
2016 [2]. NCDs also accounted for 61% of global disability 
adjusted life years (DALYs) in 2016, around 20% higher 
than in 1990, [3] with the highest rise observed in LMICs 
settings. Musculoskeletal conditions account for a significant 
proportion of NCDs contributing to DALYs, with osteoar-
thritis (OA) contributing most to this burden. OA carries an 
excess mortality and financial burden both societally and to 
individuals suffering from it [4], and is a major contributor 
to the global disability burden, with an increase of 9·6% 
of the global age-standardised years lived with disability 
(YLD) between 1990 and 2017 [5]. The Global Burden of 
Disease (GBD) study (2015) ranked OA and diabetes high-
est in terms of largest increase in years lived with disability 
when compared to the other top causes of disability [6].
Osteoarthritis is an important public health issue and 
is the most common type of arthritis [7], with 10% of the 
world’s population aged 60 years and above having health 
problems attributed to OA [8]. It is clinically characterised 
by joint pain, stiffness and functional limitation. Osteoar-
thritis is common in the joints of the knees, hands, hips, and 
feet, while also affecting the joints of the shoulder and the 
spine. The exact cause of OA is unknown, but it is thought to 
be related to ageing, whilst also associated with modifiable 
(trauma, obesity, lack of exercise) and non-modifiable risk 
factors (gender, age, genetics) [9]. The economic cost asso-
ciated with OA is enormous, ranging from direct treatment 
and care costs to lost work productivity [3, 10–12].
To date, the majority of research on musculoskeletal dis-
orders has been conducted in high-income settings, with lim-
ited data only from LMICs despite findings from the GBD 
2010 study suggesting that the prevalence of arthritis may 
be higher in LMICs [13]. Furthermore, where evidence from 
LMICs is available it is typically from the upper middle-
income group without much evidence from the lower mid-
dle income and the low-income countries that make up the 
remaining LMICs bloc.
Existing evidence is generally country specific with dis-
parate methodologies and estimates within regions. In the 
Africa region estimates vary between 4.88 and 36.8% [14, 
15], 2.96% and 56.99% in East Asia Pacific [16, 17] and 
1.42 and 83.73 in South Asia [18, 19]. The aim of this study, 
therefore, is to provide a robust evidence synthesis of data 
on the prevalence of OA in lower middle and low-income 
countries which has always been under-represented and will 
be a rising contributor to YLD. We aimed to pool data from 
population-based studies in different regions of low-income 
and lower middle-income countries to calculate contempo-
rary prevalence estimates of OA.
Methods
Search strategy and selection criteria
We performed a systematic search in four electronic bib-
liographic databases: MEDLINE, EMBASE, CINAHL and 
Web of Science from database inception to October 2018. 
Terms (both subject headings and text words) were com-
bined for osteoarthritis (including OA, arthrosis, degenera-
tive, knee pain, hip pain, hand pain, joint pain, finger pain, 
thumb pain), prevalence [including incidence, occurrence, 
disease rate, disease frequency, disease pattern), and LMICs 
(including developing countries and specifically named 
countries) [see Supplementary table S1 for the search strat-
egy]. It is important to note that our search strategy incorpo-
rated LMICs which comprises of low-income, lower middle 
and upper-middle-income countries, but it was at the selec-
tion stage that we restricted included studies to low-income 
and lower middle-income economies. Reference lists of eli-
gible studies and review articles were also assessed.
We included population-based studies of adults and ado-
lescents (aged 15 years or over) that reported prevalence 
estimates of OA in low-income and lower middle-income 
countries (see detail exclusion and inclusion criteria in 
Table 1). Studies were excluded if the study population were 
not based in a lower middle and low-income countries, if 
they included other types of arthritis such as rheumatoid 
arthritis or if they were editorials, expert reviews, com-
mentaries and traditional reviews. Searches were limited to 
human studies only, without any other limitations applied 
including language and year of publication to maximise the 
opportunity for study inclusion. Low-income countries are 
defined as economies with Gross National Income (GNI) per 
capita, calculated using the World Bank Atlas method, of 
$995 or less in 2018, while lower middle-income countries 
are those with a GNI per capita of more than $996 but less 
than $3895 [20, 21].
Two reviewers (IY and TW) independently checked 
study eligibility. All the identified articles were initially 
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screened by their titles and the resulting studies by abstract 
to determine potential eligibility. In the event of discrepan-
cies, agreement was reached by consensus and by discus-
sion with a third reviewer (TH). The full texts of potentially 
eligible studies were obtained and further assessed by the 
two reviewers (IY and TW) for final inclusion. At this stage, 
all upper middle-income countries were excluded, retaining 
only the low-income and lower middle-income countries.
Data extraction was undertaken by two reviewers inde-
pendently (IY and TW) using a pre-designed extraction 
proforma. Data extracted included information on country 
and region of study, income category, study setting, type of 
study, sampling strategy, sample size, study design, mean 
age, diagnostic criteria for OA, site of OA, and effect esti-
mates (prevalence). The countries were grouped by regions 
and income according to World Bank development indica-
tors [21]. The total prevalence estimates were only calcu-
lated from studies that provided prevalence data.
Risk of bias was assessed by two reviewers independently 
(IY and TW) using an adapted version of the risk of bias tool 
for prevalence studies [22]. This is a validated and widely 
adopted measure used to assess bias in cross-sectional stud-
ies. The checklist consists of ten questions, with a maximal 
score of 1 for each question. A score of 1 (yes) or 0 (no) was 
assigned to each question, and scores summed across ques-
tions to generate an overall quality score that ranged from 
0 to 10. An overall score of 0–4, 5–7 and 8–10 were used 
to classify the study as either high, moderate or low risk 
of bias. Any disagreement was resolved through consensus. 
The items for this tool are included in the electronic supple-
mentary material. Given the limited published data on OA 
from LMICs we included conference abstracts within our 
analysis providing they had achieved the data requirements 
for the study.
Data analysis
Meta-analysis was undertaken using the random effect 
model as there were anticipated variations in the study pop-
ulation and methodologies. Heterogeneity was assessed by 
inspecting the forest plots and using the Chi-squared test for 
heterogeneity with a 10% level of statistical significance, and 
using the I2 statistic, where we interpreted a value of 50% as 
representing moderate heterogeneity [23]. Publication bias 
was assessed by funnel plot asymmetry and Egger’s test 
for regression asymmetry [24]. We used the “trim and fill” 
analysis of Duval and Tweedie [25] to examine the poten-
tial impact of missed or unpublished studies on the pooled 
estimates of OA prevalence.
OA prevalence estimate was reported with 95% confi-
dence interval (CI). Analyses were conducted using Stata 
Statistical Software release 15 (State Corp, college Station, 
TX) using the “metaprop” routine [26].
The systematic review rationale, objectives and protocol 
were pre-specified and published in PROSPERO register 
(CRD42018112870) [27] and reported according to pre-
ferred Reporting Items for Systematic Reviews and Meta-
analysis (PRISMA) guidelines [28].
Results
Figure 1 shows the study flowchart. We identified 7414 arti-
cles from the electronic search, of which 2525 were dupli-
cates. After initial screening of abstract, 356 articles were 
selected for full text screening. Three hundred and twenty-
two (322) studies were excluded for not meeting the selec-
tion criteria, leaving 34 studies to be included in the review. 
The reasons for exclusion are provided in Fig. 1.
Supplementary table S2 summarizes the characteristics 
of the included studies. In total, 80,000 people from 25 
countries were included in this review. Most of the stud-
ies were conducted in India (n = 11) [18, 29–38] and Nige-
ria (n = 7) [29–45]. Three of the studies were conducted in 
each of Vietnam [16, 46, 47] and Bangladesh [48–50], two 
from Sri Lanka [51, 52] and Philippines [17, 53], while one 
study each from Indonesia [54], Democratic Republic of 
Congo [14], Pakistan [55], Burkina Faso [15], Ukraine [56] 
and Cameroon [57] (see included countries and regions in 
Table 2). More than half of the participants in the studies 
were female. Of the included studies, 27 (79%) were con-
ducted between 2005 and 2017, with only seven (21%) stud-
ies being published before 2005.
Table 1  Study inclusion and exclusion criteria
Inclusion Exclusion
Population Adults and adolescents (15 years and above +) Adolescents and children under 15 years of age
Outcome OA prevalence defined based on ACR definition OA prevalence not reported
Study design Population-based studies: cross-sectional studies Hospital-based studies, reviews, policy report, 
other primary study designs i.e. not cross-
sectional






Osteoarthritis was defined using American College of 
Rheumatology (ACR) criteria or using self-reported physi-
cian diagnosis. ACR criteria was used in 38% [13] of the 
studies, while the remaining were based on self-reported 
physician/clinical diagnosis 12 (35%) or COPCORD based 
questionnaire eight (24%). In 50% (n = 17) of the included 
studies, the site of OA was the knee [17, 18, 33, 34, 37, 38, 
42, 47–50, 54, 55], 38% (n = 13) was generalised OA [14, 
15, 29–32, 35, 36, 44–46, 53, 57], while the remaining 11% 
(n = 4) of the studies were either hand OA [56], spine OA 
[47] or the site was not stated [39, 43].
Thirty one of the included studies used point prevalence 
as a measure while it was unclear what prevalence estimate 
was used in two  [18, 35] of the included studies. Only one 
of the studies [39] used period prevalence as a measure of 
estimate. 94·1% (n = 32) of the studies included a mixed 


















Additional records identified through 
other sources 
(n = 8)






Full-text articles assessed for 
eligibility 
(n = 356)




34 secondary sources eg 
review/editorial
18 full text unavailable
11 wrong study design
23 wrong patient population 
5 duplicates 
173 upper middle income 
countries 
Studies included in 
qualitative synthesis 
(n = 34)
Studies included in 
quantitative synthesis (meta-
analysis) 
(n = 34 )
Records excluded 
after title screening 
(n = 3928)
Fig. 1  PRISMA flow diagram showing study selection
Table 2  Regions and countries included in the study
Regions Countries
East Asia and Pacific Indonesia, Philippines, Vietnam
Europe and Central Asia Ukraine
South Asia Bangladesh, Pakistan, India, Sri Lanka
Sub-Saharan Africa Nigeria, Democratic Republic of 
Congo, Burkina Faso, Cameroon
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population, comprising of both males and females. Only 
5·8% (n = 2) of the studies [37, 52] used male or female 
population.
The summary of the risk of bias assessment is shown 
in supplementary table S3. Of the 34 included studies, 11 
(32·4%) had moderate risk of bias [15, 17, 30, 39, 42–45, 
48, 56, 57], and four (11·8%) had high risk of bias [14, 18, 
33, 35].
The prevalence estimates of OA based on individual 
study/country is shown in Fig. 2. The prevalence of OA 
in this population varied widely across the countries. 
The prevalence varied from 5·49% (95% CI 4.77–6.29) 
to 36·80% (95% CI 34.35–39.30) in Sub-Saharan Africa 
(SSA), from 2·96% (1.92–4.33) to 56·99% (53.11–60.11) 
in East Asia and Pacific (EAP), from 1·42% (1.00–1.94) 
to 83·73% (78.02–88.46) in South Asia (SA). The reported 
prevalence of OA ranges from 1.42 (1.00–1.94) [19] to 
83.73 (78.02–88.46) [18]. The pooled OA prevalence from 
all included studies was 16.05 (12.55–19.89). The I2 was 
99·50% indicating a high level of heterogeneity across 
the studies. The funnel plot for assessing publication bias 
(Fig. 3) was asymmetrical, indicating a potential for pub-
lication bias. This was also confirmed by Egger’s test (p 
value = 0·001) for small-study effect.
The results of the sub-group analysis are shown in 
Figs. 2, 4, 5. The knee is the prevalent site of OA, with a 
reported prevalence of 20·72% (14.72–27.45). There was 
no evidence of differential burden of OA across different 
sub-regions except for one outlier study each from South 
Asia and Europe/Central Asia (Fig. 2). The reported prev-
alence estimates were higher among studies with small 
samples than those from moderate and large sample sizes 
(27.8% vs 14.60% vs 6.72%). Similarly, the reported preva-
lence estimates tended to be higher among low quality 
studies than those reported by moderate and high-quality 
studies.
Fig. 2  Forest plot showing 
the OA prevalence estimates 




Secular trend in OA prevalence is shown in (Supplemen-
tary figure S1). We observed a continuous increasing trend 
in the prevalence of OA. The studies in the 90’s recorded a 
low prevalence ranging from 2·96 [17] to 3·7% [55], while the 
more recent studies showed an increasing trend with the most 
recent between 2010 and 2017 recording a prevalence as high 
as 57% [47].
The results of the study-level factors associated with 
the variations in the OA prevalence estimates are shown in 
Table 3. The results of the meta-regression analysis showed 
that publication year, study sample size, quality score and 
country-income categories were significantly associated 
with the variations in the prevalence estimates. For every 
10-year increase in the study publication, the prevalence of 
OA increased by 10% (OR = 1.10, 95% CI 1.00–1.20) (Sup-
plementary figure S1). As the study sample sizes (Supple-
mentary figure S2) and study quality score (Supplementary 
figure S3) increases, the prevalence estimates reduces by 3% 
and 4%, respectively. The prevalence of OA tended to increase 
as the percentage of females included in the study increases 
(Supplementary figure S4). Country-income category (23.7%) 
explained the highest between studies variance, followed by 
OA sites (19.3%) and study sample size (13.6%).
Discussion
This systematic review of the prevalence of OA in lower 
middle- and low-income countries has brought together evi-
dence from 34 cross-sectional studies from the last 25 years, 
incorporating 80,000 participants. These studies were une-
venly distributed with Nigeria and India, both lower mid-
dle income countries, accounting for about a third of the 
included studies. It is one of the first systematic reviews 
undertaken investigating the prevalence of OA specifically 
in lower middle- and low-income countries. This review 
highlights that OA is an important public health problem 
in these countries with 1 in 6 persons affected by the condi-
tion. This reinforces the fact that OA is highly prevalent, 
irrespective of setting, making it a major public health prob-
lem in the world that hitherto has rarely been considered. 
The prevalence estimates observed are comparable with the 
studies conducted in other regions of the world [58–60]. For 
example, using data from Framingham study, Kim and col-
leagues [58] estimated that the prevalence of OA in adults 
aged 50 years was 19.6%.
Our findings suggest that there is an increasing trend in 
the prevalence of OA over time, with more recent studies 
recording higher prevalence of the condition. The exact 
reason for the reported high prevalence or the increasing 
trend in the prevalence of OA in the lower middle- income 
and low-income countries is likely to be multifactorial. The 
reported rising trend in the burden of disease due to OA may 
reflect increasing life expectancy, and prolonged exposure 
to arthritis risk factors such as obesity, occupational fac-
tors, joint overuse, mechanical injury, genetics and gender 
[59]. Although the prevalence of OA increases with age, it 
can occur at any age, affecting people’s ability to work and 
hence personal earnings, activities of daily living, therefore, 
impacting on overall personal and societal productivity. For 
Fig. 3  Funnel plot
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LMICs, the burden does not stop there, but further worsens 
the vicious cycle of disease and poverty [61]. There is also 
an established link between lower educational attainment, 
lower skilled job [62] and many chronic diseases including 
OA. The link could be explained by those with lower educa-
tional attainment having lower paid jobs of which most are 
long-term manual jobs and may involve heavy lifting and 
squatting [63, 64] and which for many LMICs represent a 
significant source of GDP income. This is not to imply that 
poverty in LMICs is a cause for OA, but rather, its impact 
more significant and potential for prevention and or treat-
ment less in places in the world where healthcare is limited 
or unaffordable.
The overall quality of the included studies was moderate 
with more than half of the studies assessed as having a low 
risk of bias and about a third of them assessed as having a 
moderate risk of bias. This is a strength of this study as it 
makes it highly unlikely that sampling bias has impacted 
the overall prevalence of OA. Another strength lies in the 
comprehensive searches that were conducted to ensure that 
all relevant studies/publications were identified.
Potential bias was also reduced while conducting this 
review by ensuring that the different steps of the review from 
screening of the abstracts to the data extraction stage were 
independently carried out. There was reasonable coverage of 
evidence in three of the geographical regions (SSA, SA and 
EAP), which make up the vast majority of the low-middle 
income countries. This allows for generalisability of the 
results across these regions. However, there is limited data 
to provide evidence for other regions like Latin America and 
the Caribbean.
Several limitations have to be acknowledged. The high 
degree of heterogeneity across included studies was a major 
limitation in this study. The heterogeneity could be explained 
by the differences in population characteristics and study 
methodologies. The heterogeneity observed between the 
Fig. 4  Forest plot showing the 
OA prevalence estimates by 




studies may have been as a result of cultural or geographical 
differences as well as methodological differences employed 
in the studies. Despite the heterogeneity, it was still observed 
that the pooled estimate for each of the sub regions was still 
modest, especially in the three sub-regions of SSA, EAP 
and SA with pooled estimates of 14·21 (7·95–21·89), 15·72 
(5·31–30·25) and 16·37 (11·60–21·78), respectively.
A further limitation relates to generalisability. While 
there were primary studies of reasonable quality within 
some of the sub-regions, studies from Nigeria, India and 
Bangladesh predominated, making the results unlikely to be 
generalisable. We also found some evidence of publication 
bias in this review. However, studies have shown that testing 
for publication bias in the presence of significant hetero-
geneity may lead to false-positive result [65]. Despite our 
ability to estimate the prevalence of OA, we were unable to 
examine the potential impact of different factors or potential 
correlates of OA including obesity and socioeconomic status 
which may have a role in predicting the distribution of OA. 
We can infer from the risk of bias result that the prevalence 
estimate from this review may not fulfil the rule of generalis-
ability because the included studies were not representative 
of the national population.
In conclusion, based on available evidence, we found a 
high level of OA in low and lower middle income countries. 
There is a need for development of public health strategies 
for prevention and early management. In addition, future 
studies should examine the impact of OA on individuals and 
society as a whole in these settings.
Supplementary Information The online version contains supplemen-
tary material available at https:// doi. org/ 10. 1007/ s00296- 021- 04838-y.
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